Biomedical materials, sourced under ISO 13485
Implant-grade titanium, medical PEEK, bioresorbable polymers, hydrogels and bioceramics — sourced from Chinese suppliers with ISO 13485 quality systems and ISO 10993 biocompatibility documentation.
Biomedical materials sit inside a regulated quality system
Biomedical materials are the substrates from which medical devices, implants and drug-delivery products are made. The category is unusual for a sourcing partner because the spec is set as much by regulation as by chemistry. ISO 13485 governs the supplier's quality system. ISO 10993 governs biocompatibility testing. The relevant device standard (e.g. ISO 5832 for orthopaedic implants) governs the chemistry and mechanical requirements. Customs has its own opinions on top.
Sourcing Captain works with a small group of Chinese suppliers that already hold ISO 13485 certification and ship into European and US medical device supply chains. We are explicit about the regulatory bracket of every order before it is placed: research-only material is sold and labelled differently from device-grade material, and we will not let one substitute for the other.
The category covers implant-grade titanium and cobalt-chromium alloys, medical PEEK, bioresorbable polymers (PLA, PLGA, PCL), hydrogels, hyaluronic acid, bioceramics (HA, β-TCP, bioactive glass) and tissue-engineering scaffolds. Where the application is Class II or Class III, the regulatory documentation becomes as important as the material itself.
Why a sourcing partner is non-negotiable in this category
The downside in biomedical materials is not a rejected lot — it is a recalled device. A material that drifts on chemistry or impurities, that comes from a supplier whose quality system has lapsed, or whose biocompatibility test was performed on a different lot, can take a buyer all the way to a regulatory action. The cost of that scenario is measured in millions of dollars and headlines.
A sourcing partner who insists on ISO 13485 supplier qualification, captures the original biocompatibility data tied to the supplied lot, and refuses to substitute is the difference between a clean device file and a regulatory crisis. We are conservative on this category by design.
Biomedical sourcing — six steps
Regulatory bracket
Confirm the device class and the regulatory framework before approaching any supplier.
Spec & QMS
Material spec plus the supplier QMS requirement (ISO 13485) written into the buyer dossier.
Audit
Supplier QMS audit at the China facility — annual minimum, more often for Class III work.
Sample lot
A small lot for chemistry, mechanical and (where relevant) biocompatibility verification.
Bulk PO
Locked-price PO with per-batch documentation and an inspection clause.
Release & ship
Lot release with chemistry, biocompatibility statement and supplier QMS certificate before shipment.
Per-lot biomedical release pack
Chemistry & impurities
Per-batch chemistry tied to the production lot, with the impurities required by the relevant device standard.
Biocompatibility statement
ISO 10993 biocompatibility data referenced to the lot or to a representative master lot, with traceability.
Supplier QMS certificate
Current ISO 13485 certificate copy, with the audit date.
Mechanical data
For metallics — tensile, yield and elongation per the relevant device standard.
Sample retain
Sealed retain held under controlled storage in our China warehouse.
Sourcing dossier
PDF audit, certificates and per-batch data bundled for the buyer device file.
Biomedical FAQs
Which biomedical materials do you cover?
Implant-grade titanium (Grade 2, 5, 23 / Ti-6Al-4V ELI), CoCrMo (ASTM F1537), 316LVM stainless, medical PEEK and PEKK, bioresorbable polymers (PLA, PLGA, PCL, PGA), hyaluronic acid and hydrogels, and bioceramics (hydroxyapatite, β-TCP, bioactive glass). For specific Class III chemistries we will scope with the buyer up front.
Can you supply ISO 5832-compliant titanium?
Yes. Our titanium implant suppliers ship to ISO 5832-2 (CP titanium) and ISO 5832-3 (Ti-6Al-4V), with chemistry, mechanical and microstructural data per lot.
Will you source for Class III implant programs?
Yes, but we are conservative — we audit the supplier on site, require the original biocompatibility data tied to the lot, and reject any supplier whose QMS audit is stale. The relationship is set up before the first order, not in parallel with it.
How do you handle confidentiality on device IP?
NDA is mandatory in this category. The NDA covers Sourcing Captain and the participating suppliers, and our internal sourcing dossier is built so that the buyer's downstream device design is never visible to anyone who does not need to know.
Will you support a regulatory inspection?
Yes. We retain audit and lot data per supplier and we make it available to the buyer's notified body or FDA on request, under NDA. Our customers in this category have been inspected several times with our documentation in scope and we have never been a finding.
Continue exploring
Tell us what you need to source
Send specs, target volumes, and timelines. Our sourcing team replies within one business day with a sourcing plan and price guidance.